The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive Impairment in Geriatric Patients (MoCA)
This is a prospective, double-blinded, control trial. The Montreal Cognitive Assessment is used to screen preoperative mild cognitive impairment in 582 consecutive geriatric patients, scheduled for general, vascular or urological surgery under general and/or regional anesthesia.
Mild Cognitive Impairment
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Principal Investigator|
- Incidence of mild cognitive impairment in preoperative geriatric patients [ Time Frame: 1 Year ] [ Designated as safety issue: Yes ]
- Relationship between mild cognitive impairment and drug used preoperatively in geriatric patients [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]Pearson correlation coefficient will be used to evaluate the relationship between mild cognitive impairment and drug used preoperatively in geriatric patients.
|Study Start Date:||January 2012|
|Estimated Study Completion Date:||April 2015|
|Estimated Primary Completion Date:||April 2015 (Final data collection date for primary outcome measure)|
At the preoperative visit, the co-researcher invites 322 general and vascular patients (male 190, female 132) and 260 urological patients (male 220, female 40) who meet the inclusion criteria to join the study. The process of the project is explained to the interested patients in details before an informed consent is obtained.
All participants are interviewed by using the Montreal Cognitive Assessment test. The history of drug used preoperatively (medication reconciliation) has also been recorded.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01496222
|Faculty of Medicine Siriraj Hospital|
|Bangkoknoi, Bangkok, Thailand, 10700|
|Principal Investigator:||Phongthara Vichitvejpaisal, M.D., Ph.D.||Faculty of Medicine Siriraj Hospital|